chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Dyspnoea, Hypoaesthesia oral, Pain in extremity, Pharyngeal swelling
Clinical narrative: pain in  arm; toungue feels thick; injection site bled a lot at the time of the injection; my throat began swelling a little bit; my lips got numb; I was short of breath; my voice changed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath) and DYSPHONIA (my voice changed) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath), DYSPHONIA (my voice changed) and TONGUE DISORDER (toungue feels thick). On 07-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in  arm). At the time of the report, VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath), DYSPHONIA (my voice changed) and TONGUE DISORDER (toungue feels thick) had resolved and PAIN IN EXTREMITY (pain in  arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  The patient received diphenhydramine 25mg as treatment.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue disorder, Vaccination site haemorrhage
Clinical narrative: pain in  arm; toungue feels thick; injection site bled a lot at the time of the injection; my throat began swelling a little bit; my lips got numb; I was short of breath; my voice changed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath) and DYSPHONIA (my voice changed) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath), DYSPHONIA (my voice changed) and TONGUE DISORDER (toungue feels thick). On 07-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in  arm). At the time of the report, VACCINATION SITE HAEMORRHAGE (injection site bled a lot at the time of the injection), PHARYNGEAL SWELLING (my throat began swelling a little bit), HYPOAESTHESIA ORAL (my lips got numb), DYSPNOEA (I was short of breath), DYSPHONIA (my voice changed) and TONGUE DISORDER (toungue feels thick) had resolved and PAIN IN EXTREMITY (pain in  arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  The patient received diphenhydramine 25mg as treatment.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Oropharyngeal pain, Pharyngeal swelling, Pyrexia, Rhinorrhoea
Clinical narrative: runny nose; discomfort in the throat and swollen; discomfort in the throat; Low grade fever after after the first dose and still ongoing; pain in his throat, the fleshy thing in your throat that hags down, has been swollen and remains like that and has pain in the throat; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), PHARYNGEAL SWELLING (discomfort in the throat and swollen), OROPHARYNGEAL DISCOMFORT (discomfort in the throat), PYREXIA (Low grade fever after after the first dose and still ongoing) and OROPHARYNGEAL PAIN (pain in his throat, the fleshy thing in your throat that hags down, has been swollen and remains like that and has pain in the throat) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event and Kidney transplant in 2016.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 30-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (pain in his throat, the fleshy thing in your throat that hags down, has been swollen and remains like that and has pain in the throat). On 01-Feb-2021, the patient experienced RHINORRHOEA (runny nose), PHARYNGEAL SWELLING (discomfort in the throat and swollen), OROPHARYNGEAL DISCOMFORT (discomfort in the throat) and PYREXIA (Low grade fever after after the first dose and still ongoing). At the time of the report, RHINORRHOEA (runny nose), PHARYNGEAL SWELLING (discomfort in the throat and swollen), OROPHARYNGEAL DISCOMFORT (discomfort in the throat), PYREXIA (Low grade fever after after the first dose and still ongoing) and OROPHARYNGEAL PAIN (pain in his throat, the fleshy thing in your throat that hags down, has been swollen and remains like that and has pain in the throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Tiny little red dots on legs; Rash on face, neck, torso, top of feet, leg and injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Tiny little red dots on legs) and RASH (Rash on face, neck, torso, top of feet, leg and injection site) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced ERYTHEMA (Tiny little red dots on legs) and RASH (Rash on face, neck, torso, top of feet, leg and injection site). At the time of the report, ERYTHEMA (Tiny little red dots on legs) and RASH (Rash on face, neck, torso, top of feet, leg and injection site) had resolved.            Concomitant medication not provided. Treatment medication not provided. Awaiting for Linked Case ID
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Tachycardia
Clinical narrative: Tachycardia; Drowsiness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness). On 05-Feb-2021, TACHYCARDIA (Tachycardia) and SOMNOLENCE (Drowsiness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medications were not provided by reporter.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dry mouth, Fatigue
Clinical narrative: Dry mouth; Weak; Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), ASTHENIA (Weak) and FATIGUE (Feeling tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DRY MOUTH (Dry mouth), ASTHENIA (Weak) and FATIGUE (Feeling tired). At the time of the report, DRY MOUTH (Dry mouth), ASTHENIA (Weak) and FATIGUE (Feeling tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment details included Tylenol.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Pain, Pain in extremity
Clinical narrative: started experiencing lower leg pain; uncle pain in the back and front; uncle pain in the back and front; Can hardly walk; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (started experiencing lower leg pain), ARTHRALGIA (uncle pain in the back and front), PAIN (uncle pain in the back and front) and GAIT DISTURBANCE (Can hardly walk) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included PARACETAMOL (TYLENOL) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (started experiencing lower leg pain), ARTHRALGIA (uncle pain in the back and front), PAIN (uncle pain in the back and front) and GAIT DISTURBANCE (Can hardly walk). At the time of the report, PAIN IN EXTREMITY (started experiencing lower leg pain), ARTHRALGIA (uncle pain in the back and front), PAIN (uncle pain in the back and front) and GAIT DISTURBANCE (Can hardly walk) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included Tylenol. Concomitant medications also included Blood pressure medications.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Pruritus, Throat irritation
Clinical narrative: Cough; itchiness; throat irritation; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache). At the time of the report, COUGH (Cough), PRURITUS (itchiness), THROAT IRRITATION (throat irritation) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Vomiting
Clinical narrative: Chills; Bad Headache; fatigue; Body ache; Vomited; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Bad Headache), FATIGUE (fatigue), MYALGIA (Body ache) and VOMITING (Vomited) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced CHILLS (Chills), HEADACHE (Bad Headache), FATIGUE (fatigue), MYALGIA (Body ache) and VOMITING (Vomited). On 08-Feb-2021, CHILLS (Chills), HEADACHE (Bad Headache), FATIGUE (fatigue), MYALGIA (Body ache) and VOMITING (Vomited) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site big; Injection site hot; Injection site red; Injection site sore; Injection site big; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDURATION (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE SWELLING (Injection site big) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced INJECTION SITE INDURATION (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE SWELLING (Injection site big). At the time of the report, INJECTION SITE INDURATION (Injection site big), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE PAIN (Injection site sore) and VACCINATION SITE SWELLING (Injection site big) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching rash; Bilateral rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching rash) and RASH (Bilateral rash) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypersensitivity reaction. Concomitant products included ESTRADIOL (MINIVELLE) for Hysterectomy, TOPIRAMATE for Nerve injury, LEVOTHYROXINE for Thyroid nodule removal, VITAMIN D NOS for Vitamin D deficiency, AMLODIPINE for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PRURITUS (Itching rash) and RASH (Bilateral rash). On 17-Feb-2021, PRURITUS (Itching rash) and RASH (Bilateral rash) had resolved.            Concomitant medications includes levofiranta, steroid treatment medication includes Antihistamines   Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: Follow-up information received contain significant information added updated address, Batch number of second dose and concomitant medications added, updated action taken.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Rash, Urticaria
Clinical narrative: Rash covered mostly arms and butt; Welts covered mostly arm and butt; Rash all over; lips swollen twice the size as normal; Welts on butt; Rash on butt; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lips swollen twice the size as normal), URTICARIA (Welts on butt), RASH (Rash on butt), RASH (Rash all over) and RASH (Rash covered mostly arms and butt) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced LIP SWELLING (lips swollen twice the size as normal), URTICARIA (Welts on butt) and RASH (Rash on butt). On 07-Feb-2021, the patient experienced RASH (Rash all over). On 08-Feb-2021, the patient experienced RASH (Rash covered mostly arms and butt) and URTICARIA (Welts covered mostly arm and butt). At the time of the report, LIP SWELLING (lips swollen twice the size as normal) had resolved and URTICARIA (Welts on butt), RASH (Rash on butt), RASH (Rash all over), RASH (Rash covered mostly arms and butt) and URTICARIA (Welts covered mostly arm and butt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (side effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (side effect). At the time of the report, ADVERSE REACTION (side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was a little sore). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Arm was hot to touch; Soreness in arm; Redness in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm was hot to touch), VACCINATION SITE PAIN (Soreness in arm) and VACCINATION SITE ERYTHEMA (Redness in arm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Arm was hot to touch), VACCINATION SITE PAIN (Soreness in arm) and VACCINATION SITE ERYTHEMA (Redness in arm). On 26-Jan-2021, VACCINATION SITE WARMTH (Arm was hot to touch), VACCINATION SITE PAIN (Soreness in arm) and VACCINATION SITE ERYTHEMA (Redness in arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Red big spot on site of injection; Itchiness; Natural soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red big spot on site of injection), VACCINATION SITE PRURITUS (Itchiness) and MYALGIA (Natural soreness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, METOPROLOL SUCCINATE, HYDROCHLOROTHIAZIDE, LOSARTAN and PARACETAMOL (TYLENOL) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red big spot on site of injection), VACCINATION SITE PRURITUS (Itchiness) and MYALGIA (Natural soreness). At the time of the report, VACCINATION SITE ERYTHEMA (Red big spot on site of injection), VACCINATION SITE PRURITUS (Itchiness) and MYALGIA (Natural soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: feeling crappy/feeling unwell; Myalgia; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling crappy/feeling unwell) and MYALGIA (Myalgia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling crappy/feeling unwell) and MYALGIA (Myalgia). At the time of the report, MALAISE (feeling crappy/feeling unwell) and MYALGIA (Myalgia) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: TCR was received Contains No New Information
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: developed a rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (developed a rash at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (developed a rash at the injection site). At the time of the report, VACCINATION SITE RASH (developed a rash at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the right arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history.).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the right arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the right arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were given No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Got sick from after taking the covid shot; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Got sick from after taking the covid shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Got sick from after taking the covid shot). At the time of the report, MALAISE (Got sick from after taking the covid shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Vomiting
Clinical narrative: stomach ache; very bad diarrhea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (very bad diarrhea) and VOMITING (vomiting) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (very bad diarrhea) and VOMITING (vomiting). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (very bad diarrhea) and VOMITING (vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Patient called to report that she received the Moderna Covid-19 on 2 Feb 2021 in her left arm. After vaccination, the patient started experiencing stomach ache, vomiting, very bad diarrhea. Patient wanted to know what to do now, and why she need to receive the second dose of Moderna COVID vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Non-significant FU added.Declined email address or fax number
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Limb discomfort, Myalgia
Clinical narrative: muscle pain; Couldn't move arm; Eczema worse; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MYALGIA (muscle pain), LIMB DISCOMFORT (Couldn't move arm) and ECZEMA (Eczema worse) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0741L20-A) for COVID-19 vaccination.     The patient's past medical history included Eczema since an unknown date. Concomitant products included PREDNISONE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), LIMB DISCOMFORT (Couldn't move arm) and ECZEMA (Eczema worse). At the time of the report, MYALGIA (muscle pain) and LIMB DISCOMFORT (Couldn't move arm) outcome was unknown and ECZEMA (Eczema worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain on the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on the site of injection) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain on the site of injection). At the time of the report, VACCINATION SITE PAIN (pain on the site of injection) outcome was unknown. Not Provided          No relevant Concomitant medications were reported.   No Treatment information for the event was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on the site of injection) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain on the site of injection). At the time of the report, VACCINATION SITE PAIN (pain on the site of injection) outcome was unknown. Not Provided          No relevant Concomitant medications were reported.   No Treatment information for the event was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: sharp chest pain after I got home from getting my vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (sharp chest pain after I got home from getting my vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (sharp chest pain after I got home from getting my vaccine). At the time of the report, CHEST PAIN (sharp chest pain after I got home from getting my vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: tingling on the lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling on the lips) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and GI upset.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PARAESTHESIA ORAL (tingling on the lips). On 05-Feb-2021, PARAESTHESIA ORAL (tingling on the lips) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included medications to treat high blood pressure and GI problems.  Treatment medication included Tylenol.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site pain
Clinical narrative: my arm was sore underneath; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and AXILLARY PAIN (my arm was sore underneath) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was sore). On 05-Feb-2021, the patient experienced AXILLARY PAIN (my arm was sore underneath). At the time of the report, VACCINATION SITE PAIN (arm was sore) and AXILLARY PAIN (my arm was sore underneath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pyrexia, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: discomfort; slight fever; rash on arm; that started to itch; Painful on the site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Painful on the site), PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (that started to itch) and DISCOMFORT (discomfort) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Fish oil and Vitamin D for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Painful on the site). On 06-Feb-2021, the patient experienced PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm) and VACCINATION SITE PRURITUS (that started to itch). On 07-Feb-2021, the patient experienced DISCOMFORT (discomfort). At the time of the report, VACCINATION SITE PAIN (Painful on the site), PYREXIA (slight fever), VACCINATION SITE RASH (rash on arm), VACCINATION SITE PRURITUS (that started to itch) and DISCOMFORT (discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hard; hot reaction; itchy; swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot reaction), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M2077) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot reaction), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (hot reaction), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Neck pain, Vaccination site erythema
Clinical narrative: Neck pain; Headache; Redness at injection site; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Redness at injection site) and MYALGIA (Muscle pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced NECK PAIN (Neck pain), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Redness at injection site) and MYALGIA (Muscle pain). At the time of the report, NECK PAIN (Neck pain), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Redness at injection site) and MYALGIA (Muscle pain) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Erythema, Headache, Pruritus
Clinical narrative: Red; Swollen; Itchy; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), SWELLING (Swollen), PRURITUS (Itchy), CHILLS (Chills) and PYREXIA (Fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 20-Feb-2021, the patient experienced ERYTHEMA (Red), SWELLING (Swollen) and PRURITUS (Itchy). At the time of the report, ERYTHEMA (Red), SWELLING (Swollen), PRURITUS (Itchy), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.         The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Reporter contact details were updated.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: Red; Swollen; Itchy; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red), SWELLING (Swollen), PRURITUS (Itchy), CHILLS (Chills) and PYREXIA (Fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 20-Feb-2021, the patient experienced ERYTHEMA (Red), SWELLING (Swollen) and PRURITUS (Itchy). At the time of the report, ERYTHEMA (Red), SWELLING (Swollen), PRURITUS (Itchy), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.         The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Reporter contact details were updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: first shot produced a very unpleasant reaction; left arm swelled; the band was about 3 or 4 inches in height, it was extremely itchy; red band that was almost all the way around my arm; Indurated wider area; after initial swelling went down, it reappeared about 8 days later; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (first shot produced a very unpleasant reaction), VACCINATION SITE SWELLING (left arm swelled), VACCINATION SITE SWELLING (after initial swelling went down, it reappeared about 8 days later), VACCINATION SITE PRURITUS (the band was about 3 or 4 inches in height, it was extremely itchy) and VACCINATION SITE ERYTHEMA (red band that was almost all the way around my arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (first shot produced a very unpleasant reaction), VACCINATION SITE SWELLING (left arm swelled), VACCINATION SITE SWELLING (after initial swelling went down, it reappeared about 8 days later), VACCINATION SITE PRURITUS (the band was about 3 or 4 inches in height, it was extremely itchy), VACCINATION SITE ERYTHEMA (red band that was almost all the way around my arm) and VACCINATION SITE INDURATION (Indurated wider area). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 06-Feb-2021 for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION COMPLICATION (first shot produced a very unpleasant reaction), VACCINATION SITE SWELLING (left arm swelled), VACCINATION SITE SWELLING (after initial swelling went down, it reappeared about 8 days later), VACCINATION SITE PRURITUS (the band was about 3 or 4 inches in height, it was extremely itchy), VACCINATION SITE ERYTHEMA (red band that was almost all the way around my arm) and VACCINATION SITE INDURATION (Indurated wider area) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-246800 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow up received on 05-JUL-2021 contains no new information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: arm was Itchy; arm was blotchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm was Itchy) and RASH (arm was blotchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Obesity.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (arm was Itchy) and RASH (arm was blotchy). At the time of the report, PRURITUS (arm was Itchy) and RASH (arm was blotchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Paraesthesia oral, Rhinorrhoea, Sneezing
Clinical narrative: lot of coughing; sneezing; runny nose; felt really tired; tingling on the lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling on the lips), COUGH (lot of coughing), SNEEZING (sneezing), RHINORRHOEA (runny nose) and FATIGUE (felt really tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Gastrointestinal discomfort.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PARAESTHESIA ORAL (tingling on the lips). On 06-Feb-2021, the patient experienced FATIGUE (felt really tired). On 08-Feb-2021, the patient experienced COUGH (lot of coughing), SNEEZING (sneezing) and RHINORRHOEA (runny nose). On 05-Feb-2021, PARAESTHESIA ORAL (tingling on the lips) had resolved. On 06-Feb-2021, FATIGUE (felt really tired) had resolved. At the time of the report, COUGH (lot of coughing), SNEEZING (sneezing) and RHINORRHOEA (runny nose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.